The effect of using a large language model to respond to patient messages
- PMID: 38664108
- PMCID: PMC11829255
- DOI: 10.1016/S2589-7500(24)00060-8
The effect of using a large language model to respond to patient messages
Conflict of interest statement
DSB reports being an Associate Editor of Radiation Oncology at HemOnc.org (no financial compensation, unrelated to this work, and recieving funding from American Association for Cancer Research, unrelated to this work. HJWLA reports advising and consulting for Onc.AI, Love Health, Sphera, Editas, AstraZeneca, and Bristol Myers Squibb, unrelated to this work. RHM reports being on an Advisory Board for ViewRay and AstraZeneca; Consulting for Varian Medical Systems and Sio Capital Management; and honorarium from Novartis and Springer Nature. JL reports research funding from Viewray, NH Theraguix, and Varian. ML reports advisory and consulting for Pfizer, Gilead, Novartis, and AstraZeneca, unrelated to this work. BHK reports research funding from Botha-Chan Low Grade Glioma Consortium (National institutes of Health [NIH]-USA K08DE030216-01). All other authors declare no competing interests. The authors acknowledge financial support from the Woods Foundation (DSB, RHM, BHK, and HJWLA) NIH (NIH-USA U54CA274516-01A1 (SC, MG, BHK, HJWLA, GKS, and DSB), NIH-USA U24CA194354 (HJWLA), NIH-USA U01CA190234 (HJWLA), NIH-USA U01CA209414 (HJWLA), and NIH-USA R35CA22052 (HJWLA), NIH-NIDA R01DA051464 (MA), R01GM114355 (GKS), NIH-USA R01LM012973 (TM and MA), NIH-USA R01MH126977 (TM), NIH-USA U54 TW012043-01 (JG and LAC), NIH-USA OT2OD032701 (JG and LAC), NIH-USA R01EB017205 (LAC), and the EU European Research Council (HJWLA 866504), all outside of the submitted work. All data collected and generated in this study, after de-identification, are available at https://github.com/AIM-Harvard/OncQA. SC: conceptualisation, data curation, formal analysis, investigation, methodology, visualisation, and writing (original draft, review, and editing). MG: conceptualisation, data curation, and formal analysis. SM, FH EH, BHK, FEC, JL: data curation, investigation, and methodology. RHM: data curation, investigation, methodology, and writing (review and editing). HJWLA: investigation, methodology, resources, and writing (review and editing). JG: formal analysis, investigation, methodology, visualisation, and writing (review and editing). TM and GKS: formal analysis, investigation, methodology, and writing (review and editing). ML data curation, formal analysis, investigation, and methodology. LAC formal analysis, investigation, supervision, and writing (review and editing). MA: conceptualisation, data curation, formal analysis, investigation, methodology, supervision, and writing (review and editing). DSB: conceptualisation, data curation, formal analysis, investigation, methodology, supervision, visualisation, resources, and writing (original draft, review, and editing). SC and DSB directly accessed and verified the underlying data reported in the manuscript. All authors have full access to all the data in the study and accept responsibility to submit for publication.
Figures

Comment in
-
From text to treatment: the crucial role of validation for generative large language models in health care.Lancet Digit Health. 2024 Jul;6(7):e441-e443. doi: 10.1016/S2589-7500(24)00111-0. Lancet Digit Health. 2024. PMID: 38906607 No abstract available.
References
-
- Adler-Milstein J, Zhao W, Willard-Grace R, Knox M, Grumbach K. Electronic health records and burnout: time spent on the electronic health record after hours and message volume associated with exhaustion but not with cynicism among primary care clinicians. J Am Med Inform Assoc 2020; 27: 531–38. - PMC - PubMed
-
- Epic. Epic and Microsoft bring GPT-4 to EHRs. May 5, 2023. https://www.epic.com/epic/post/epic-and-microsoft-bring-gpt-4-to-ehrs (accessed March 1, 2024).
Grants and funding
- R01 EB017205/EB/NIBIB NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- R01 GM114355/GM/NIGMS NIH HHS/United States
- U54 TW012043/TW/FIC NIH HHS/United States
- R01 CA294033/CA/NCI NIH HHS/United States
- OT2 OD032701/OD/NIH HHS/United States
- U54 CA274516/CA/NCI NIH HHS/United States
- K08 DE030216/DE/NIDCR NIH HHS/United States
- U01 CA209414/CA/NCI NIH HHS/United States
- R01 MH126977/MH/NIMH NIH HHS/United States
- R01 LM012973/LM/NLM NIH HHS/United States
- U01 CA190234/CA/NCI NIH HHS/United States
- R01 DA051464/DA/NIDA NIH HHS/United States
- U24 CA194354/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources